UBS Group’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-78,389
| Closed | -$1.86M | – | 10443 |
|
|
2023
Q3 | $1.86M | Buy |
78,389
+29,009
| +59% | +$546K | ﹤0.01% | 3504 |
|
|
2023
Q2 | $801K | Buy |
49,380
+19,382
| +65% | +$321K | ﹤0.01% | 4435 |
|
|
2023
Q1 | $522K | Buy |
29,998
+6,410
| +27% | +$115K | ﹤0.01% | 4651 |
|
|
2022
Q4 | $443K | Buy |
23,588
+16,949
| +255% | +$327K | ﹤0.01% | 4816 |
|
|
2022
Q3 | $118K | Buy |
6,639
+4,505
| +211% | +$78.2K | ﹤0.01% | 5567 |
|
|
2022
Q2 | $37K | Sell |
2,134
-17,886
| -89% | -$341K | ﹤0.01% | 6173 |
|
|
2022
Q1 | $419K | Sell |
20,020
-29,727
| -60% | -$569K | ﹤0.01% | 4811 |
|
|
2021
Q4 | $886K | Buy |
49,747
+24,701
| +99% | +$397K | ﹤0.01% | 4497 |
|
|
2021
Q3 | $353K | Buy |
25,046
+8,916
| +55% | +$139K | ﹤0.01% | 4947 |
|
|
2021
Q2 | $267K | Sell |
16,130
-20,622
| -56% | -$370K | ﹤0.01% | 5153 |
|
|
2021
Q1 | $665K | Sell |
36,752
-6,244
| -15% | -$123K | ﹤0.01% | 4633 |
|
|
2020
Q4 | $784K | Buy |
42,996
+17,081
| +66% | +$271K | ﹤0.01% | 4216 |
|
|
2020
Q3 | $330K | Buy |
25,915
+25,365
| +4,612% | +$324K | ﹤0.01% | 4478 |
|
|
2020
Q2 | $6K | Sell |
550
-39,791
| -99% | -$412K | ﹤0.01% | 7324 |
|
|
2020
Q1 | $421K | Sell |
40,341
-33,590
| -45% | -$433K | ﹤0.01% | 4124 |
|
|
2019
Q4 | $1.19M | Buy |
73,931
+28,427
| +62% | +$470K | ﹤0.01% | 4041 |
|
|
2019
Q3 | $713K | Buy |
45,504
+19,254
| +73% | +$320K | ﹤0.01% | 4260 |
|
|
2019
Q2 | $522K | Buy |
26,250
+21,395
| +441% | +$400K | ﹤0.01% | 4266 |
|
|
2019
Q1 | $82K | Sell |
4,855
-37,402
| -89% | -$649K | ﹤0.01% | 5217 |
|
|
2018
Q4 | $641K | Buy |
42,257
+9,240
| +28% | +$159K | ﹤0.01% | 4078 |
|
|
2018
Q3 | $663K | Buy |
33,017
+5,032
| +18% | +$107K | ﹤0.01% | 4196 |
|
|
2018
Q2 | $546K | Buy |
27,985
+25,793
| +1,177% | +$408K | ﹤0.01% | 4251 |
|
|
2018
Q1 | $30K | Sell |
2,192
-5,101
| -70% | -$67.2K | ﹤0.01% | 6091 |
|
|
2017
Q4 | $99K | Sell |
7,293
-736
| -9% | -$10.6K | ﹤0.01% | 5359 |
|
|
2017
Q3 | $126K | Buy |
8,029
+7,019
| +695% | +$113K | ﹤0.01% | 5175 |
|
|
2017
Q2 | $17K | Sell |
1,010
-127
| -11% | -$1.93K | ﹤0.01% | 6425 |
|
|
2017
Q1 | $17K | Sell |
1,137
-6,144
| -84% | -$90.5K | ﹤0.01% | 6278 |
|
|
2016
Q4 | $95K | Buy |
7,281
+4,591
| +171% | +$58.8K | ﹤0.01% | 5334 |
|
|
2016
Q3 | $30K | Sell |
2,690
-42,411
| -94% | -$509K | ﹤0.01% | 5940 |
|
|
2016
Q2 | $537K | Sell |
45,101
-2,305
| -5% | -$31K | ﹤0.01% | 3827 |
|
|
2016
Q1 | $723K | Buy |
47,406
+45,218
| +2,067% | +$686K | ﹤0.01% | 3504 |
|
|
2015
Q4 | $35K | Sell |
2,188
-2,823
| -56% | -$41.2K | ﹤0.01% | 6187 |
|
|
2015
Q3 | $62K | Sell |
5,011
-2,021
| -29% | -$27.7K | ﹤0.01% | 5637 |
|
|
2015
Q2 | $117K | Buy |
7,032
+4,751
| +208% | +$76.5K | ﹤0.01% | 5276 |
|
|
2015
Q1 | $36K | Sell |
2,281
-183
| -7% | -$3.03K | ﹤0.01% | 6357 |
|
|
2014
Q4 | $38K | Buy |
+2,464
| New | +$36K | ﹤0.01% | 6833 |
|
Other funds holding NXGN
UBS Group's NXGN Position: Q4 2023 in Review
UBS Group sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 78,389 shares — an estimated $1.86M sold.
UBS Group first reported a position in NXGN in Q4 2014 and held it in 36 quarters. The position peaked at $1.86M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- UBS Group reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 78,389 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $1.86M.
- UBS Group first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2014 and held it in 36 quarters.
- UBS Group's NextGen Healthcare, Inc. Common Stock position peaked at $1.86M in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.